Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001951578 | SCV002238473 | pathogenic | Fanconi anemia | 2021-01-31 | criteria provided, single submitter | clinical testing | The region of the FANCA gene that includes exon(s) 21-29 has been determined to be clinically significant (PMID: 21273304, 29269525). Therefore, deletions that encompass that region are likely to disrupt protein function and cause disease. This variant has not been reported in the literature in individuals with FANCA-related conditions. This variant is a gross deletion of the genomic region encompassing exon(s) 18-31 of the FANCA gene. This variant would be expected to be in-frame, preserving the integrity of the reading frame. For these reasons, this variant has been classified as Pathogenic. |